XML 26 R19.htm IDEA: XBRL DOCUMENT v3.20.1
Net loss per share
3 Months Ended
Mar. 31, 2020
Net loss per share  
Net loss per share

13. Net loss per share

Basic and diluted net loss per share attributable to ordinary shareholders was calculated as follows (in thousands, except share and per share amounts):

 

 

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 31, 

 

    

2020

    

2019

Numerator:

 

 

 

 

 

 

Net loss attributable to ordinary shareholders

 

$

(11,324)

 

$

(6,503)

Denominator:

 

 

  

 

 

  

Weighted average ordinary shares outstanding, basic and diluted

 

 

17,997,929

 

 

834,043

Net loss per share attributable to ordinary shareholders, basic and diluted

 

$

(0.63)

 

$

(7.80)

 

The Company’s potentially dilutive securities which include share options, and which prior to the completion of the IPO included convertible preferred shares, warrants to subscribe for Series A and Series B1 Preferred Shares, and unvested restricted shares, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share. Therefore, the weighted average number of ordinary shares outstanding used to calculate both basic and diluted net loss per share attributable to ordinary shareholders is the same. The Company excluded the following potentially dilutive ordinary shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to ordinary shareholders for the periods indicated because including them would have had an anti‑dilutive effect:

 

 

 

 

 

 

 

 

Three Months Ended

 

 

March 31, 

 

    

2020

    

2019

Convertible preferred shares (as converted to ordinary shares)

 

 —

 

11,647,529

Warrants to subscribe for convertible preferred shares (as adjusted to reflect the impact of the share capital reorganization and issuance of bonus shares (Note 6))(1)(2)

 

71,450

 

1,347,953

Restricted ordinary shares

 

 —

 

56,643

Options to purchase ordinary shares

 

3,654,888

 

930,861

 

 

3,726,338

 

13,982,986


(1)

On March 7, 2019, the holders of the Series B1 warrants to subscribe for Series B1 Preferred Shares agreed that 50% of the warrants would be exercised in conjunction with the IPO and 50% of the warrants would expire.  

(2)

At March 31, 2020, 50,000 warrants are outstanding which are exercisable into 71,450 ordinary shares (Note 6).